Your session is about to expire
← Back to Search
Treatment (RBX7455) for Breast Cancer (RBX7455 Trial)
RBX7455 Trial Summary
This trial studies the side effects of RBX7455 before surgery in treating patients with operable breast cancer. RBX7455 contains live intestinal microbes, which may help to restore the normal balance of microorganisms in the intestines.
- Breast Cancer
RBX7455 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRBX7455 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RBX7455 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must use a reliable form of birth control during the study, such as birth control pills, condoms or an intrauterine device.You are able to swallow capsules and are willing to do so.You agree not to take any probiotics, except for those found in food, for 8 weeks after finishing the study drug.
- Group 1: Treatment (RBX7455)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being recruited for this research trial?
"Affirmative, the details published on clinicaltrials.gov illustrate that this medical trial is still recruiting participants. It was first made available to public review on August 31st 2020 and most recently updated on May 12th 2022 with a target of 30 patients across 2 research sites."
Has RBX7455 been officially sanctioned by the Food and Drug Administration?
"Due to the limited evidence available for both safety and efficacy, our team at Power assigned RBX7455 a score of 1."
Are new participants being recruited for this scientific experiment?
"Regulatory data on clinicaltrials.gov suggests that this medical trial is currently recruiting for participants. The study was first introduced to the public in August 2020 and has seen an update as recently as May 2022."
Share this study with friends
Copy Link
Messenger